ArticleBlood cancer journal2024

Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.

Camille Gondran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.